New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MDT;COV;INTC;BSX;VRTX;JNJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
April 24, 2015
12:35 EDTINTCAltera retreats after weak earnings that Intel reportedly saw coming
Subscribe for More Information
09:38 EDTINTCIntel may still consider Altera deal, but no talks ongoing, CNBC says
Subscribe for More Information
09:37 EDTINTCIntel not in ongoing talks with Altera currently, CNBC's Faber says
05:52 EDTINTCIntel to help vendors launch inexpensive Android tablets, DigiTimes reports
Subscribe for More Information
April 23, 2015
14:20 EDTJNJEarnings Watch: Google up close to 8.5% since last earnings report
Subscribe for More Information
11:02 EDTJNJJohnson & Johnson increases dividend by 7.1% to 75c
Subscribe for More Information
10:02 EDTJNJAbbVie says communication with Johnson & Johnson has been 'very positive'
Subscribe for More Information
05:53 EDTINTCIntel to launch SoFIA LTE chips in Q4, DigiTimes reports
Subscribe for More Information
April 22, 2015
18:27 EDTINTCSemiconductor stocks under pressure after TI, Qualcomm report financial results
Semiconductor stocks are under pressure after earnings reports from Texas Instruments (TXN) and Qualcomm (QCOM). TEXAS INSTRUMENTS: TI reported first quarter results that were lower than analyst expectations, and gave second quarter guidance below consensus estimates. In its Q1 earnings press release, Texas Instruments said its outlook for Q2 is for earnings per share between 60c-70c and revenue in the range of $3.12B-$3.38B. "Our estimates assume continuing weakness in our communications equipment and personal electronics markets, particularly for wireless infrastructure equipment and PCs, respectively. We also do not expect a near-term rebound in foreign currency exchange rates. The annual effective tax rate for 2015 is expected to be about 30%." QUALCOMM: Qualcomm reported Q2 results that were better than analyst's average estimates, but lowered its fiscal year 2015 EPS and revenue views. Qualcomm CEO Steve Mollenkopf said, "While we remain confident in the significant growth opportunities ahead, we are reducing our QCT outlook for fiscal 2015, primarily due to the increased impact of customer share shifts within the premium tier and a decline in our share at a large customer." PRICE ACTION: In after-hours trading, shares of Texas Instruments are down over 6%, while Qualcomm shares are down almost 3%. Other publicly traded companies in the space include AMD (AMD), Intel (INTC), Marvell (MRVL), Microchip (MCHP), Micron (MU), NVIDIA (NVDA), Altera (ALTR), Xilinx (XLNX), and Maxim Integrated (MXIM).
14:47 EDTINTCEarnings Watch: Texas Instruments reports amid M&A focus in semiconductor space
Texas Instruments (TXN) is expected to report first quarter earnings after the close on Wednesday, April 22, with a conference call scheduled for 5:30 pm ET. Texas Instruments is a global semiconductor manufacturer operating in four segments: Analog, Embedded Processing, Wireless and Other. EXPECTATIONS: Analysts are looking for earnings per share of 62c on revenue of $3.2B. The consensus range is 61c-64c for EPS on revenue of $3.18B-$3.21B, according to First Call. On its last earning call, Texas Instruments said it expected Q1 EPS of 57c-67c and revenue of $3.07B-$3.33B. LAST QUARTER: On January 26, Texas Instruments reported adjusted fourth quarter EPS of 69c, which matched consensus expectations at that time. Its Q4 revenue of $3.27B came in just above the consensus forecast of $3.26B. Texas Instruments said its inventory ended the quarter at 117 days and noted on its associated conference call that it believe inventories were at "healthy levels." Texas Instruments also said then that it expected its embedded operating margins to increase. STREET RESEARCH: The day after TI's last quarterly report, Ascendiant raised its price target for Texas Instruments shares to $64 from $56 and reiterated a Buy rating on the stock. The firm attributed the post-earnings slide the stock experienced then to profit taking, rather than a fundamental disappointment. That same week, Argus increased its price target on Texas Instruments to $62 from $54 and said it expected the company's operating trends to continue to strengthen. Argus kept a Buy rating on the shares. Acquiring companies in the semiconductor space "can materially outperform the market," Jefferies analyst Mark Lipacis wrote in a note to investors on March 9. At that time, Lipacis identified Texas Instruments, NXP Semiconductors (NXPI), Avago (AVGO), Marvell (MRVL), Maxim Integrated (MXIM), Broadcom (BRCM), Altera (ALTR), and Xilinx (XLNX) as companies that were well-positioned to make acquisitions in the future. WHAT'S NOTABLE: On March 1, NXP Semiconductors and Freescale Semiconductor (FSL) announced that they have entered into a definitive agreement under which NXP will merge with Freescale in a transaction valuing the combined enterprise at just over $40B. Recent media reports suggested that Intel's (INTC) talks to acquire Altera stalled when the latter wanted more than Intel was willing to pay. PRICE ACTION: Since the day after last quarter's report, Texas Instruments' stock has rallied nearly 7%. In afternoon trading, Texas Instruments gained over 1% to $58.76.
12:31 EDTINTCOn The Fly: Top stock stories at midday
Stocks on Wall Street were higher at midday after having been on a bit of a see-saw during morning trading. The averages opened in positive territory, soon turned negative, then back into positive ground following the release of a better than expected existing home sales report. The housing data was followed by a lift in the averages, which remained in positive ground near noon. ECONOMIC EVENTS: In the U.S., existing home sales rose 6.1% to a 5.19M rate in March, which was better than the expected 3.1% increase to a rate of 5.03M. Crude oil inventories built up by 5.32M barrels last week, which was more than the consensus forecast for a 3.2M barrel build. In Asia, Japan's Nikkei 225 average closed above 20,000 for the first time since April 2000. In Europe, Germany raised its economic growth forecast for 2015 to 1.8%, which was up from the 1.5% growth it said it expected in January. COMPANY NEWS: Shares of McDonald's (MCD) advanced 2% after the company reported headline earnings that missed expectations but also said it is developing a turnaround plan to improve its performance and deliver "enduring profitable growth" that it plans to share in the first week of May. Also rising after its quarterly report was another globally recognized brand, Coca-Cola (KO), whose shares gained 1% after its comparable earnings per share topped the consensus estimate. A third member of the Dow, Boeing (BA), slid over 2.5% after its earnings beat expectations but its revenue fell short of the consensus forecast... Visa (V) rose 5% and MasterCard (MA) advanced over 4% after China's State Council announced overnight that the country will regulate the market access for bankcard transaction clearing institutions, which analysts think might allow both companies to compete for the processing of domestic transactions in the country. MAJOR MOVERS: Among the notable gainers was Angie's List (ANGI), which jumped 12% after the company reported it was profitable in the first quarter and announced an exclusive relationship that will see carpet manufacturer Shaw Industries give the company's members exclusive product offers. Also higher was ASML (ASML), which gained 11% after announcing that it has signed an agreement with one of its "major U.S. customers" to deliver a minimum of 15 ASML EUV, or Extreme Ultraviolet, lithography systems. Afterward, Summit Research said it thinks the most likely buyer is Intel (INTC), which the firm believes does not want to be left behind if TSMC (TSM) puts EUV to use in 10nm processing. Among the noteworthy losers was Natural Resource Partners (NRP), which dropped 19% after the company slashed its quarterly distribution by 75% to 9c per unit. Also lower following their earnings reports were ADTRAN (ADTN), which fell over 9%, Cree (CREE), which slid 9%, and Chipotle Mexican Grill (CMG), which declined 6%. INDEXES: Near midday, the Dow was up 28.69, or 0.16%, to 17,978.28, the Nasdaq was up 6.66, or 0.13%, to 5,020.77, and the S&P 500 was up 5.24, or 0.25%, to 2,102.53.
10:11 EDTINTCHouse Committee on Small Business to hold a hearing
The Committee holds a hearing entitled, "Small Business: Big Threat: Protecting Small Businesses From Cyber Attacks" with Chief Technology Officer Grobman of Intel on April 22 at 11 am.
09:37 EDTINTCAltera quarterly results 'may not be great,' CNBC's Faber reports
There is talk that Altera's (ALTR) earnings report "may not be great" when the chip company reports Q1 results on Thursday, April 23, CNBC's David Faber reports. Investors assume Altera will report a strong quarter after turning down Intel's takeover attempt, but that may not be the case, according to Faber. Shares of the chip maker are down 35c to $42.89 in early trading. Piper Jaffray this morning downgraded the stock to Neutral.
09:32 EDTINTCASML large EUV tool order likely from Intel, says Summit Research
Subscribe for More Information
05:43 EDTINTCAltera downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Ruben Roy downgraded Altera (ALTR) to Neutral from Overweight saying takeover speculation has driven the valuation above a fundamentals based fair value. He believes an acquisition by Intel (INTC) makes sense, but at a reasonable valuation. The analyst thinks a higher premium than $54 per share is unlikely. Piper keeps a $42 price target for shares of Altera. Roy still views the longer-term prospects for the programmable logic device companies favorably and thinks Altera is better positioned near-term versus Xilinx (XLNX). Shares of Altera closed yesterday up 8c to $43.24.
April 21, 2015
13:34 EDTVRTXGilead paying premium to buy Vertex not warranted right now, says Maxim
After Bernstein suggested in a note to investors earlier that Gilead (GILD) should buy Vertex (VRTX), Maxim responded in its own note that it does not believe paying a premium to buy Vertex makes sense before the company has data showing efficacy for Kalydeco in heterozygotes. Maxim keeps a Hold rating and $121 price target on Vertex shares.
12:33 EDTVRTXOn The Fly: Top stock stories at midday
Subscribe for More Information
12:21 EDTVRTXVertex rises after Bernstein suggests Gilead should pursue takeover
Subscribe for More Information
11:02 EDTMDTMedtronic begins enrollment in feasibility study of Valiant Mona LSA system
Medtronic announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for aortic aneurysms encroaching on the left subclavian artery. Cleveland Clinic cardiothoracic surgeon Dr. Eric Roselli successfully completed the first implant in the study on Thursday. He serves as the study's national primary investigator and receives consulting fees and honoraria for teaching from Medtronic. The study aims to enroll 24 subjects at up to seven sites in the United States. The purpose of the study is to characterize the safety and effectiveness of the investigational device acutely and at 30 days.
10:55 EDTINTCStreet Check: Lam Research defenders rewarded with post-earnings jump
Subscribe for More Information
08:14 EDTVRTXGilead should buy Vertex, says Bernstein
Subscribe for More Information
07:06 EDTINTCRe/Code to hold a conference
Subscribe for More Information
April 20, 2015
16:09 EDTBSXBoston Scientific announces long-term data underscore safety, efficacy of S-ICD
The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific S-ICD System for patients at risk of sudden cardiac arrest. The study, "Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-year Results from a Pooled Analysis of the IDE Study and EFFORTLESS Registry" was led by Dr. Martin Burke, professor of medicine at the University of Chicago. The analysis combined data from two large S-ICD studies to provide the most comprehensive look at S-ICD System patient outcomes to date. The all-cause mortality rate for the S-ICD patients was 1.6% per year, comparing favorably to observed mortality rates in similar TV-ICD studies. Currently, the S-ICD System is covered nationally by Medicare, Aetna, Cigna and others, and regionally by numerous private and Medicaid plans, providing coverage for approximately 170M individuals in the U.S. The S-ICD System has been commercially available in Europe since 2009.
14:32 EDTJNJPharmacyclics patent for Imbruvica challenged by Hayman Capital's Bass
Subscribe for More Information
07:44 EDTBSXSurvey shows strong momentum for Boston Scientific devices, says RBC Capital
RBC Capital says that its survey supports strong momentum for Boston Scientific's S-ICD and Watchman, and the firm thinks the company is probably gaining share in single-chamber ICDs. The firm raised its price target on the shares to $20 from $17 and recommends buying the shares at current levels or on pullbacks.
07:30 EDTINTCApplied Materials added to Franchise Picks list at Jefferies
Jefferies added Applied Materials (AMAT) to its Franchise Picks list with the stock down 14% year-to-date. The firm attributes the pullback to concerns around tool reuse, and notes it still expects foundry capital spending to increase amid "increased process complexity and competition." Jefferies' work indicates TSMC's (TSM) and Intel's (INTC) capex cuts were driven by market share losses rather than innovation in tool reuse. It keeps a Buy rating on AMAT with a $29 price target.
06:59 EDTJNJJohnson & Johnson added to short-term buy list at Deutsche Bank
Subscribe for More Information
05:26 EDTINTCEricsson announces collaboration with Intel security
Subscribe for More Information
April 17, 2015
16:31 EDTJNJStocks end week lower amid earnings reports, fear about Greece, China
Subscribe for More Information
10:14 EDTINTCOptions with decreasing implied volatility
Subscribe for More Information
10:02 EDTINTCIntel upgraded to Buy from Neutral at Tigress Financial
07:10 EDTMDTMedtronic's Solitaire improved neurological outcomes in stroke patients in trial
Subscribe for More Information
April 16, 2015
16:11 EDTBSXBoston Scientific enrolls first patient REDUCE-HTN: REINFORCE study
Boston Scientific announced the first patient in the REDUCE-HTN: REINFORCE study was enrolled this week at Cardiology P.C. at Princeton Baptist Medical Center in Birmingham, AL by Farrell Mendelsohn, M.D., site principal investigator, and referred by Michael Wilensky, M.D. Boston Scientific received an investigational device exemption, or IDE, for the study from the FDA in December.
10:15 EDTINTCOptions with decreasing implied volatility
Subscribe for More Information
09:57 EDTINTCXilinx rallies after dealReporter discusses potential takeout
Subscribe for More Information
09:48 EDTJNJGenmab achieves $10M milestone in daratumumab collaboration with Janssen
Subscribe for More Information
09:36 EDTINTCActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL NFLX NEE AMT WFM C PM INTC AA MCD
08:06 EDTINTCIntel upgraded at Bernstein
Subscribe for More Information
07:53 EDTINTCAltera options indicate traders still hoping for deal, Reuters says
Subscribe for More Information
06:58 EDTINTCIntel upgraded to Market Perform from Underperform at Bernstein
05:52 EDTINTCIntel makes push into mini desktop market in 2015, DigiTimes reports
Intel plans to push into the mini desktop market in 2015, reports DigiTimes. According to sources from the upstream supply chain, Intel is also aggressively promoting its Compute Stick and aiming to ship 1.2M units in 2015. Currently, Intel is seeing strong demand for mini desktops in Europe, Southeast Asia and Japan. Reference Link
05:50 EDTINTCIntel to step up cooperation with ODMs and white-box vendors, DigiTimes reports
Intel will look to step up its cooperation with ODMs and white-box makers in China to strengthen its presence in China's handset market, reports DigiTimes. According to industry sources, some vendors will use Intel's quad-core solutions for its 3G smartphones in 3Q15 and 4G LTE models in 4Q15. Reference Link
April 15, 2015
16:27 EDTINTCOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
15:53 EDTINTCAltera cases illustrates challenges Intel may face in dealmaking, WSJ says
Subscribe for More Information
12:30 EDTINTCOn The Fly: Top stock stories at midday
Stocks on Wall Street began the session in positive territory for the fifth time in the past six sessions. The move came amid lower than expected manufacturing data and industrial production figures in the U.S. and a report on Chinese GDP growth that matched expectations. Although the averages remain higher near midday, the market is well off its highs as investors await the release of the Fed’s Beige Book report. ECONOMIC EVENTS: In the U.S., the Empire State manufacturing report had a reading of -1.19, versus expectations for a 7.17 reading. Industrial production fell 0.6% in March, versus expectations for a 0.3% decline. Capacity utilization came in at 78.4% during the month, versus the 78.6% that was forecast. NAHB's homebuilder confidence index climbed to 56 in April, versus expectations for a reading of 55. The Federal Reserve is scheduled to release its Beige Book at 2 pm EDT this afternoon. In China, the nation's GDP grew at a 7.0% rate in Q1, which met expectations but was the lowest level of quarterly growth since 2009. A number of March data releases came in below expectations in China, including reports on industrial production, retail sales and fixed investments. In Europe, the European Central Bank kept interest rates unchanged. COMPANY NEWS: The European Commission announced it has opened a formal investigation of whether Google’s (GOOG, GOOGL) conduct in relation to its Android mobile operating system as well as applications and services for smartphones and tablets has breached EU antitrust rules. The Commission also sent a Statement of objections to Google alleging the company has abused its dominant position in the markets for general internet search services in the European Economic Area by favoring its own comparison shopping product in its general search results pages. For its part, Google's SVP of Google Search Amit Singhal said the company "respectfully but strongly" disagrees with the need to issue a statement of objections and looks forward to making its case... After Intel (INTC) reported results that were in-line with its preannouncement and estimated that its 2015 revenue would be roughly flat year-over-year, shares rose 4.5%. However, analysts disagreed on the company's ability to meet its revised outlook, with Wedbush upgrading the stock to Outperform from Neutral, but Citi saying that the company's guidance was too bullish and keeping a Neutral rating on the shares. MAJOR MOVERS: Among the notable gainers was Celsion (CLSN), which gained 20% after the company announced interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox in recurrent chest wall breast cancer. Also higher was gunmaker Smith & Wesson (SWHC), which gained 13% after raising its guidance, citing orders throughout its fiscal fourth quarter that have been stronger than originally anticipated. Among the noteworthy losers was Alcatel-Lucent (ALU), which dropped 19% after agreeing to merge with Nokia (NOK) in an all-share transaction that values Alcatel-Lucent at EUR 15.6B on a fully diluted basis. Also lower were shares of Precision Castparts (PCP), which fell 3% after the company issued fourth quarter guidance, said it was making headcount reductions and the stock was downgraded at DA Davidson. INDEXES: Near midday, the Dow was up 56.39, or 0.31%, to 18,093.09, the Nasdaq was up 24.52, or 0.49%, to 5,001.81, and the S&P 500 was up 9.80, or 0.47%, to 2,105.64.
10:52 EDTINTCBattleground: Analysts clash on Intel's ability to meet guidance
Subscribe for More Information
10:19 EDTINTCOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTINTCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: American Tower (AMT) upgraded to Outperform from Neutral at Macquarie... Ameriprise (AMP) upgraded at Morgan Stanley... Builders FirstSource (BLDR) upgraded to Buy from Neutral at Sterne Agee... China Telecom (CHA) upgraded to Outperform from Market Perform at Bernstein... China Unicom (CHU) upgraded to Outperform from Underperform at Bernstein... Discover (DFS) upgraded to Overweight from Neutral at JPMorgan... EV Energy (EVEP) upgraded on asset sale at RBC Capital... GoPro (GPRO) upgraded to Overweight from Neutral at Piper Jaffray... Intel (INTC) upgraded on valuation at RBC Capital... Nike (NKE) upgraded to Overweight from Neutral at Piper Jaffray... Nokia (NOK) upgraded to Market Perform from Underperform at Bernstein... Rice Energy (RICE) upgraded to Buy from Neutral at Goldman... Staples (SPLS) upgraded to Buy from Hold at BB&T... Team (TISI) upgraded to Buy from Hold at BB&T... Ulta Salon (ULTA) upgraded to Overweight from Neutral at Piper Jaffray.
09:35 EDTINTCActive equity options trading on open
Subscribe for More Information
09:08 EDTINTCOn The Fly: Pre-market Movers
Subscribe for More Information
09:07 EDTINTCIntel reported weak Q1 results, says JMP Securities
JMP Securities says that Intel's Q1 EPs was in-line with its preannouncement, while its data center demand decelerated. The firm thinks the company's guidance for flat 2015 revenue growth is overly optimistic, while data center revenue is likely to decelerate further and elevated inventory levels add risk to gross margin expectations. The firm reiterates a $27 price target and Underperform rating on the shares.
08:39 EDTINTCIntel upgraded on valuation at RBC Capital
As noted earlier, RBC Capital upgraded Intel to Outperform from Sector Perform. The firm believes that bearish PC sentiment is fully priced into the shares, while investors should focus on the company's data center business as a driver of cash flow growth. Target $40.
08:15 EDTINTCIntel reported to be in talks to buy VIA Telecom, Bloomberg says
Subscribe for More Information
08:15 EDTINTCIntel Q1 results impressive, says Wells Fargo
Wells Fargo says it was impressed by Intel's results and guidance. The firm has above consensus 2015 and 2016 EPS estimates for the company, and it reiterates an Outperform rating on the shares. Wells continues to identify the stock as a Top Pick.
08:11 EDTJNJJohnson & Johnson valuation appears attractive, says Wells Fargo
Subscribe for More Information
07:41 EDTJNJEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
06:51 EDTINTCIntel upgraded to Outperform from Neutral at Wedbush
Subscribe for More Information
06:41 EDTINTCCiti recommends Applied Materials, Lam after Intel capex cut
Subscribe for More Information
06:35 EDTINTCCiti calls Intel guidance too bullish, predicts another cut
Citigroup believes the lowered 2015 revenue and margin outlook Intel offered last night remains too bullish. The guidance bakes in 17% revenue growth for the second half of 2015, but since 2010, Intel has grown second half revenue just 5% on average and has never had more than 8% revenue growth, Citi argues. As such, the firm thinks Intel's guidance has to come down again. Citi raised its price target for Intel shares to $32 and $31 and keeps a Neutral rating on the stock following the company's Q1 results.
06:14 EDTINTCIntel upgraded to Outperform from Sector Perform at RBC Capital
Subscribe for More Information
06:05 EDTINTCIntel gross margin higher than expected, says Piper Jaffray
Piper Jaffray says that despite lower revenue, Intel's gross margin in Q1 was better than expected due to higher platform average selling prices and lower factory start-up costs. Piper notes Intel's Q2 revenue outlook of $13.2B implies a 3% revenue increase quarter-over-quarter, in line with normal seasonality but modestly below current consensus expectations for $13.5B. The firm remains positive on Intel's product strategy and focus on shareholder returns. It reiterates an Overweight rating on the stock with a $38 price target.
April 14, 2015
18:30 EDTINTCOn The Fly: After Hours Movers
Subscribe for More Information
17:53 EDTINTCIntel says expects PC market to remain 'challenging' in 2015
Says on track to improving mobile profitability goal. Says on track reduce mobile losses by $800M, weighted towards back half of year. Says PC Industry burning through inventory and expects trend to continue in Q2. Says will not respond to rumors on M&A. Says growth in Data Center group will be "lumpy" near term, but long term expects mid-teens growth. Comments from company's Q1 earnings conference call.
17:04 EDTINTCSemiconductor equipment stocks lower after Intel cuts FY15 CapEx view
Subscribe for More Information
16:53 EDTJNJOn The Fly: Top stock stories for Tuesday
Stocks on Wall Street were mixed for the day, beginning the session in positive territory helped by better than expected earnings reports from JPMorgan (JPM), Johnson & Johnson (JNJ), and Wells Fargo (WFC). The early economic data was slightly below Wall Street expectations and became a headwind for the market. By the end of the first hour of trading the market had turned negative, and it spent the remainder of the day trading in mixed fashion. ECONOMIC EVENTS: In the U.S., retail purchases for March advanced 0.9%, bouncing up from a 0.5% decline in February. However, economists had predicted a 1.1% growth after improvements on last month's weather. The producer price index grew 0.2% for March, in line with consensus estimates. Core PPI grew 0.2% versus expectations of 0.1% growth. The International Monetary Fund's World Economic Outlook Report trimmed U.S. growth forecast to 3.1% from its previous outlook of 3.6%, while global forecast was left unchanged at 3.5%. COMPANY NEWS: Avon (AVP) surged 66c, or 8.24%, to $8.67 following a Wall Street Journal report that the company is exploring strategic alternatives, including potentially selling its North American business, though a Bloomberg report later in the day claimed the company is not conducting a formal sale process... Nokia (NOK) confirmed it is in "advanced discussions" to buy French telecom firm Alcatel-Lucent (ALU), prompting French President Francois Hollande to schedule meetings with leaders from both companies. Later in the day, the French government announced it supports the potential deal, with French Economy Minister Emmanuel Macron stating Nokia reassured officials by detailing "clear undertakings." Nokia fell 34c, or 4.1%, to $7.96 at the close, while Alcatel jumped 58c, or 13.33%, to $4.93. MAJOR MOVERS: Among the notable gainers was 58.com (WUBA), which rallied 33.52%, or $17.04, to $67.87 after the Financial Times reported the company has signed a memorandum of understanding to merge with rival classifieds service Ganji.com. Also higher was PartnerRe (PRE), which advanced 8.49% to $129.25 after EXOR proposed to acquire the company for $130.00 per share in cash, valuing PartnerRe at $6.4B. Following earnings, JPMorgan (JPM) advanced 1.56% to $63.04 after beating expectations, while Wells Fargo (WFC) fell 0.73% and Johnson & Johnson fell 0.03% after reducing its FY15 earnings guidance. Among the noteworthy losers was Arrowhead Research (ARWR), which tumbled 7.75% after Jefferies downgraded the stock to Hold and lowered its price target to $9 from $30. The firm said that while ARC-520 offers the potential for a Hepatitis B virus functional cure, it prefers to wait for multi-dosing data. Also lower was Norfolk Southern (NSC), which dropped 4.18% to $100.49 and was downgraded to Hold at TD Securities following first quarter guidance that fell below expectations. INDEXES: The Dow rose 59.66, or 0.33%, to 18,036.70, the Nasdaq lost 10.96, or 0.22%%, to 4,977.29, and the S&P 500 advanced 3.41, or 0.16%, to 2,095.84.
16:41 EDTINTCIntel CFO: Q1 in came 'as projected'
Subscribe for More Information
16:11 EDTINTCIntel up 3% following Q1 results, guidance
16:10 EDTINTCIntel sees FY15 CapEx $8.7B, plus or minus $500M
Subscribe for More Information
16:08 EDTINTCIntel sees Q2 gross margin 62%, plus or minus couple of points
16:06 EDTINTCIntel sees FY15 gross margin 61%
16:06 EDTINTCIntel reports Q1 gross margin 60.5%, down 4.9 point sequentially
Subscribe for More Information
16:05 EDTINTCIntel reports Q1 Client Computing Group revenue down 16% sequentially
Down 8% y/y. Reports Q1 Data Center Group revenue down 10% sequentially, up 19% y/y.
16:04 EDTINTCIntel sees FY15 revenue approximately flat, consensus $55.69B
Subscribe for More Information
16:03 EDTINTCIntel sees Q2 revenue $13.2B, plus or minus $500M, consensus $13.51B
Subscribe for More Information
16:01 EDTINTCIntel reports Q1 EPS 41c, consensus 41c
Reports Q1 revenue $12.8B, consensus $12.9B.
16:00 EDTINTCOptions Update; April 14, 2015
Subscribe for More Information
15:34 EDTINTCNotable companies reporting after market close
Subscribe for More Information
15:13 EDTINTCIntel April 31.5 straddle priced for 4.1% movement into Q1
Subscribe for More Information
14:48 EDTJNJZimmer, Stryker have mixed read through from J&J results, says Wells Fargo
Subscribe for More Information
14:42 EDTJNJSmall spine names have positive read through from J&J results, says Wells Fargo
Subscribe for More Information
12:24 EDTJNJOn The Fly: Top stock stories at midday
Stocks on Wall Street were mixed at midday despite better than expected headline earnings from JPMorgan (JPM), Wells Fargo (WFC) and Johnson & Johnson (JNJ). The market began the session in positive territory on the heels of those solid earnings reports, but the averages were unable to hold their early gains as the retail sales figures released during the pre-market trading session missed expectations. ECONOMIC EVENTS: In the U.S., retail purchases grew 0.9% in March, rebounding from a 0.5% decline in February. However, economists were expecting a more pronounced 1.1% advance in recovery from the prior month's weather driven weakness. The producer price index rose 0.2% in March, matching expectations. The core PPI, which excludes food and energy, grew 0.2% as well, versus expectations for it to have risen 0.1%. Business Inventories grew 0.3% in February, versus expectations for them to be up 0.2%. The International Monetary Fund, in its latest World Economic Outlook Report, trimmed its U.S. growth forecast to a 3.1% pace from its prior 3.6% view, but left its global forecast intact at a 3.5% rate. COMPANY NEWS: Shares of JPMorgan advanced 1.5% after its headline earnings per share topped expectations, even before accounting for 13c per share in aftertax legal expense that the bank identified as a "significant item." Conversely, fellow large bank Wells Fargo (WFC) slid 1.5% after its own report on first quarter results, despite the fact that its earnings and revenue both topped the consensus forecast... Shares of Johnson & Johnson (JNJ) were fractionally higher at midday after its first quarter earnings and revenue beat expectations. The multinational company, however, lowered its FY15 adjusted earnings outlook, citing further negative foreign currency movements... Nokia (NOK) and Alcatel-Lucent (ALU), in response to "recent media speculation," confirmed that they are in advanced discussions with respect to a potential full combination, which would take the form of a public exchange offer by Nokia for Alcatel. MAJOR MOVERS: Among the notable gainers was 58.com (WUBA), which jumped 25% after Financial Times reported the company has signed a memorandum of understanding to merge with peer Ganji.com to create one of the largest specialized online classified companies in China. Also higher was PartnerRe (PRE), which advanced nearly 9% to trade near $129.50 after Europe based investment company EXOR announced that it submitted a written proposal to acquire 100% of the common shares of the company for $130.00 per share in cash, valuing PartnerRe at $6.4B. EXOR said its all-cash proposal represents a 16% premium to the implied value per share of $112.53 for PartnerRe under the merger deal it has in place with AXIS Capital (AXS). Among the noteworthy losers was Arrowhead Research (ARWR), which tumbled over 6% after Jefferies downgraded the stock to Hold and cut its price target for shares to $9 from $30 after assuming coverage of the stock. The firm said that while ARC-520 offers the potential for a Hepatitis B virus functional cure, it prefers to wait for multi-dosing data. Also lower was Norfolk Southern (NSC), which fell nearly 6% and was downgraded to Hold from Buy at TD Securities after the railroad operator provided first quarter guidance that came in below analysts' consensus estimates. INDEXES: Near midday, the Dow was up 53.15, or 0.3%, to 18,030.19, the Nasdaq was down 16.19, or 0.32%, to 4,972.06, and the S&P 500 was up 2.20, or 0.11%, to 2,094.63.
11:04 EDTMDTMedtronic to develop stent graft system under patent agreement with Sanford
Subscribe for More Information
09:35 EDTJNJActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN PBR SU NFLX ALU BIDU TSLA JNJ GE
09:17 EDTJNJJohnson & Johnson says capital allocation strategy remains the same
The company says it continues to view dividends as its first priority in returning capital to shareholders. The company said it is still looking at portfolio for potential exits.
09:16 EDTMDTMedtronic announces CE Mark for Micra TPS
Subscribe for More Information
09:16 EDTJNJJohnson & Johnson says FY15 guidance doesn't include biosimilar compeition
Subscribe for More Information
09:16 EDTJNJJohnson & Johnson sees FY15 EPS constant currency $6.64-46.79
Sees FY15 adjusted EPS $6.04-6.19. The company had previously announced FY15 adjusted EPS $6.12-$6.27. FY15 EPS consensus $6.16
09:13 EDTJNJOn The Fly: Pre-market Movers.
UP AFTER EARNINGS: JPMorgan Chase (JPM), up 1%... Johnson & Johnson (JNJ), up marginally... Triangle Petroleum (TPLM), up 4.2%... Fastenal (FAST), up 5%. ALSO HIGHER: Brainstorm Cell Therapeutics (BCLI), up 13.5% after announcing that it will present NurOwn Phase 2a clinical data at the Academy of Neurology annual meeting... Builders FirstSource (BLDR), up 7.2% after being upgraded to Buy from Hold at Stifel... Solazyme (SZYM), up 7.5% after announcing a strategic agreement with Flotek (FTK)... Cleveland BioLabs (CBLI), up 6.8% after receiving funding recommendation from the Department of Defense... Nordic American Tanker (NAT), up 3.2% after raising quarterly dividend to 38c from 22c... Ocwen (OCN), up 3.8% after reporting preliminary fiscal 2014 results. DOWN AFTER EARNINGS: Wells Fargo (WFC), down just under 1%. ALSO LOWER: Norfolk Southern (NSC), down 5.8% after being downgraded to Hold from Buy at TD Securities... RXi Pharmaceuticals (RXII), down 14.3% after filing to sell $20M of common stock and warrants... Arrowhead Research (ARWR), down 4.5% after being downgraded to Hold from Buy at Jefferies.
09:09 EDTBSXBoston Scientific announces strategic alliance with Frankenman
Boston Scientific announced the signing of a strategic alliance with Frankenman Medical Equipment Company, a recognized leader with deep local market expertise in the China surgical devices market. This alliance is expected to enable Boston Scientific and Frankenman to reach more clinicians and treat more patients by providing access to training on less invasive endoscopic technologies and the clinical and economic benefits these therapies can provide. CPEChina Fund, an entity of CITIC PE, is a current shareholder of Frankenman and will continue to support the company's growth in alignment with this strategic partnership.Under the terms of the agreement, Boston Scientific will become a shareholder of Frankenman, and provide services and expertise to Frankenman to support its continued growth, development pipeline and manufacturing capabilities. The transaction is expected to close in the first half of 2015, subject to customary closing conditions.
08:57 EDTJNJJohnson & Johnson backs FY15 sales $75B-$76B
Including foreign exchange, sees reported sales $70B-$71B. Consensus is $71.16B. Backs FY15 net interest expense $450M-$550M. Raises FY15 net other income expense to $2B-$2.1B from $1.5B-$1.6B. Expects R&D tax credit will be renewed by Congress. Raises FY15 effective tax rate to 21%-22% from 20%-21%. If the tax credit is not approved, it will negatively impact the tax rate by 0.5%. Comments taken from Q1 earnings conference call.
07:50 EDTJNJJohnson & Johnson reports Q1 Worldwide Consumer sales $3.4B
Subscribe for More Information
07:48 EDTJNJJohnson & Johnson cuts FY15 adjusted EPS to $6.04-$6.19 from $6.12-$6.27
Subscribe for More Information
07:46 EDTJNJJohnson & Johnson reports Q1 domestic sales up 5.9% to $8.69B
Subscribe for More Information
07:45 EDTJNJJohnson & Johnson reports Q1 adjusted EPS $1.56, consensus $1.54
Subscribe for More Information
April 13, 2015
19:18 EDTINTCOn The Fly: After Hours Movers
Subscribe for More Information
17:52 EDTINTCAltera holders Candid, Tig looking for sale to Intel, Bloomberg says
Subscribe for More Information
17:13 EDTMDTIBM Medtronic to partner to improve diabetes care
IBM (IBM) and Medtronic (MDT) announced that they will work together to combine powerful analytics and cognitive computing with diabetes medical devices and health data to develop a new generation of personalized diabetes management solutions. People using Medtronic diabetes solutions could benefit from new solutions developed in collaboration with IBM's newly-formed Watson Health unit.
17:10 EDTMDT, JNJIBM establishes a Watson Health Cloud
Subscribe for More Information
16:48 EDTINTCAltera up 1.4% following Bloomberg report of holders pushing for sale to Intel
Subscribe for More Information
16:45 EDTINTCAltera holders Candid, Tig looking for sale to Intel, Bloomberg says
16:21 EDTJNJOn The Fly: Top stock stories for Monday
Subscribe for More Information
15:38 EDTJNJNotable companies reporting before tomorrow's open
Subscribe for More Information
15:08 EDTJNJJohnson & Johnson April 100 straddle priced for 2.2% movement into Q1
14:18 EDTINTCIntel April option elevated into Q1 and outlook
Intel April call option implied volatility is at 51, May is at 27, June is at 22, October is at 21; compared to its 26-week average of 25 according to Track Data, suggesting large near term price movement into the release of Q1 results today on April 14.
14:07 EDTJNJEarnings Watch: Johnson & Johnson shares down slightly since last earnings
Subscribe for More Information
13:37 EDTINTCIntel technical notes ahead of results
The key technical feature on the 1-year chart is the potential large-scale bearish head and shoulders. That pattern began forming in October 2014. The neckline is at the $30 level. If the news is more bearish than anticipated and the $30 level is broken on the downside, the pattern will become active. Downside potential for the pattern if it remains active and completes is to the $23 to $22.50 area. On positive news, there is a smaller potential bullish inverted head and shoulders pattern that would become active above the $32.50 level which corresponds to the 50-day moving average. Upside potential for that pattern would be to the $35 to $35.50 level. Resistance above that area would be at $36.45.
13:28 EDTJNJJohnson & Johnson April volatility elevated into Q1 and outlook
Subscribe for More Information
11:12 EDTJNJJohnson & Johnson technical notes before earnings
Leading up to earnings, the shares have been trading in a narrow range largely bound by $98 at the low and $103 at the high. This trading range was preceded by a decline from the 52-week high set back in the fall of 2014. In a longer time frame, the current trading action is part of a larger potential topping process, with $95 as the midpoint. On worse than expected news, the low bound at $98 would be first important support. A breakdown below $98 would see next support at $95. A move below $95 would confirm the topping process and break the long-term uptrend. Support below $95 would be at $93.94. If results and outlook are better than expected, first resistance would be at the top of the range at $103. Next resistance would then be at $105.36. A move above that level would see $107.10, and then 52-week high and life high at $109.49 as next potential upside objectives.
April 12, 2015
19:07 EDTINTCCommerce Department block sales of Intel Xeon Phi chips to China, Gizmodo says
Subscribe for More Information
16:46 EDTINTCIntel, Seagate may rise despite potentially weak earnings reports, Barron's says
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use